Filing Details

Accession Number:
0000899243-21-035331
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-08 16:15:19
Reporting Period:
2021-09-07
Accepted Time:
2021-09-08 16:15:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1789972 Cullinan Oncology Inc. CGEM Biological Products, (No Disgnostic Substances) (2836) 813867811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1837456 Leigh Zawel C/O Cullinan Oncology, Inc.
One Main Street, Suite 520
Cambridge MA 02142
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-09-07 28,118 $28.95 65,406 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 26, 2021.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.62 to $29.29. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.